Drug Shortage Report for LIORESAL INTRATHECAL 0.5MG/ML
Report ID | 148466 |
Drug Identification Number | 02131056 |
Brand name | LIORESAL INTRATHECAL 0.5MG/ML |
Common or Proper name | LIORESAL 10MG/20ML 1X1 AMPS |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BACLOFEN |
Strength(s) | 0.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRATHECAL INTRATHECAL |
Packaging size | 1 X 1 AMPS |
ATC code | M03BX |
ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-11-05 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2021-11-11 |
Shortage status | Resolved |
Updated date | 2022-01-17 |
Company comments | Delay in product release |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-01-17 | French | Compare |
v4 | 2022-01-17 | English | Compare |
v3 | 2021-11-06 | English | Compare |
v2 | 2021-10-28 | French | Compare |
v1 | 2021-10-28 | English | Compare |
Showing 1 to 5 of 5